COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02531152
Brief Title: 28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension

First Submitted : August 20, 2015
First Submitted that Met QC Criteria : August 20, 2015
First Posted : August 24, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 26, 2016
Last Update Posted : April 27, 2016 (Estimate)